Possible protein binding displacement interaction between glibenclamide and metolazone

Area of Science:

• Pharmacology
• Drug Interactions
• Clinical Pharmacy

Background:

• Glibenclamide, a sulfonylurea, is highly protein-bound.
• Metolazone is a thiazide-like diuretic.
• Understanding drug interactions affecting protein binding is crucial for safe and effective therapy.

Observation:

• The study investigated the in vitro effect of metolazone on glibenclamide's plasma protein binding.
• Glibenclamide was studied at a concentration of 10 micrograms/ml.
• Metolazone concentrations were increased up to 100 ng/ml.

Findings:

• Increasing metolazone concentrations up to 100 ng/ml showed no significant impact on glibenclamide protein binding.
• The free fraction of glibenclamide remained largely unaffected by varying metolazone levels.
• This indicates a lack of significant displacement interaction.

Implications:

• Metolazone is unlikely to cause a clinically significant increase in the unbound fraction of glibenclamide.
• Co-prescription of metolazone with glibenclamide may not necessitate dose adjustments due to protein binding changes.
• Further clinical studies could validate these in vitro findings in patient populations.